Are there any adverse reactions?

Rare side effects include temporary itching, hair adhesion, vomiting, or neurological symptoms if licked.

What is the shelf life of the product?

The shelf life is 36 months from the date of manufacture when stored correctly.

Imidacloprid Moxidectin Spot-on Solution for Dog Cat Pet Medicine

Name: Imidacloprid Moxidectin Spot-on Solution for Dog Cat Pet Medicine
Brand: Shandong Ginye Biotech Co., Ltd.
SKU: 2038537552

Shandong, ChinaShandong Ginye Biotech Co., Ltd.

US$1.50

15,000-29,999 0.8ml

US$1.20

30,000+ 0.8ml

Sample price:US$2.20/l.Request sample

Product profile

Customization

Available

Varieties

Parasite Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Type

The First Class

Pharmacodynamic Influential Factors

Repeated Medication

Storage Method

Prevent High or LowTemperature

Veterinary Reg. No.

Shouyaozhunzihao

Transport Package

Carton or Drum

Specification

0.8ml

Trademark

Ginye

Origin

China

Production Capacity

10000L/Year

Key features

Dual-Action Formula: Combines Imidacloprid and Moxidectin for synergistic effect against internal and external parasites.

Broad Spectrum Protection: Effective against fleas, ticks, ear mites, scabies, demodex, heartworm, and gastrointestinal nematodes.

Long-Lasting Efficacy: Single dose prevents flea re-infestation for 4 weeks and provides monthly protection against heartworm.

Multiple Size Options: Available in 0.4ml, 1.0ml, 2.5ml, and 4.0ml tubes tailored for small, medium, large, and extra-large dogs.

Easy Topical Application: Simple spot-on solution applied between shoulder blades; effective even with occasional water contact.

Veterinary Grade Quality: Classified as First Class veterinary medicine with detailed pharmacological and pharmacokinetic data.

Safe for Various Breeds: Suitable for most dogs; special precautions provided for Collies and sensitive breeds regarding licking.

Company profile

Shandong Ginye Biotech Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2018-12-10Nearest Port: QINGDAOAverage Response Time: ≤3.37hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP

AI-Powered supplier vetting

SummaryShandong Ginye Biotech Co., Ltd. is a China-based private trading company and manufacturer focused on animal pharmaceuticals, feed additives, pet medicines, and related products. It reports ISO 9001 and GMP certification, two GMP factories, ten production lines in one description, six operating production lines in another, more than one hundred products, and dedicated R&D and quality-control personnel. The supplier began exporting in 2018, with exports representing 51%–70% of total sales, and reports cooperation with several animal-health research institutions. Evidence confirms production, certification, export activity, and research cooperation, but does not establish after-sales processes, customization services, audited financial strength, or a broad customer track record.

Supplier typeThe supplier is explicitly identified as both a trading company and manufacturer/factory. Its stated business includes research, production, and trading of animal pharmaceuticals, feed additives, and pet products, indicating an integrated supplier model rather than a pure intermediary.

CertificationsThe supplier reports ISO 9001 and GMP certification and states that it operates its quality management system according to GMP standards. These statements provide explicit evidence of formal quality-system and GMP compliance claims.

R&D capabilityThe supplier describes research and development as part of its core business and reports cooperation with Shandong Agricultural Academy, China Veterinary Herb Medicine Industry Research Institute, Shandong Herb Medicine University, and Shandong Agricultural University. It also states that it researches and commercializes recent research results, supporting an established innovation orientation.

Production capacityThe supplier reports two modern GMP factories, ten production lines in one description, six operating production lines in another, and more than one hundred products across multiple dosage forms. It also reports 11–20 quality-control staff and annual output data, providing explicit evidence of substantial manufacturing capacity, although the differing line counts should be clarified.

Client casesThe records show transaction or buyer associations involving Vietnam, Pakistan, and Bangladesh, including SHAH POULTRY INTERNATIONAL and CHEMBIO TECH LTD, and identify products such as CEFGIN-100 and a vitamin premix. These records demonstrate some cross-border commercial activity, but the limited number of transactions does not establish a broad or well-documented customer portfolio.